InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
CFA | Interleukin 2 Ameliorates Autoimmune Neuroinflammation by Modulating the Bala... | 2021 | Ann Clin Lab Sci. | Li J. et al. | 51(4):529-534. |
Primocin® | Identification of New Transcription Factors that Can Promote Pluripotent Repr... | 2021 | Stem Cell Rev Rep. | Huang P. et al. | DOI: 10.1007/s12015-021-10220-z |
pFUSE-hIgG2-Fc | Development of a cell line-based assay to measure the antibody-dependent cell... | 2021 | Vet Immunol Immunopathol | Mizuno T. et al. | DOI: 10.1016/j.vetimm.2021.110315 |
5'ppp-dsRNA | Mast cell phenotypic plasticity and their activity under the influence of cat... | 2021 | Cell Immunol. | Agier J. et al. | DOI: 10.1016/j.cellimm.2021.104424 |
Anti-human Dectin-2 (CLEC6A) antibody | Mast cell phenotypic plasticity and their activity under the influence of cat... | 2021 | Cell Immunol. | Agier J. et al. | DOI: 10.1016/j.cellimm.2021.104424 |
FLA-ST (Standard or Ultrapure) | Blockage of bacterial FimH prevents mucosal inflammation associated with Croh... | 2021 | Microbiome | Chevalier G. et al. | DOI: 10.1186/s40168-021-01135-5 |
HEK-Blue™ Null2 Cells | Blockage of bacterial FimH prevents mucosal inflammation associated with Croh... | 2021 | Microbiome | Chevalier G. et al. | DOI: 10.1186/s40168-021-01135-5 |
LPS-EK (LPS from E. coli K12) | Blockage of bacterial FimH prevents mucosal inflammation associated with Croh... | 2021 | Microbiome | Chevalier G. et al. | DOI: 10.1186/s40168-021-01135-5 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Blockage of bacterial FimH prevents mucosal inflammation associated with Croh... | 2021 | Microbiome | Chevalier G. et al. | DOI: 10.1186/s40168-021-01135-5 |
Poly(I:C) (HMW) VacciGrade™ | Peripheral viral challenge increases c-fos level in cerebral neurons. | 2021 | Metab Brain Dis. | Petrisko T.J. & Konat G.W. | DOI: 10.1007/s11011-021-00819-z |
Anti-hIL-1β-IgG | Inhibition of RAC1 activity in cancer associated fibroblasts favours breast t... | 2021 | Cancer Lett. | Martínez-López A. et al. | DOI: 10.1016/j.canlet.2021.08.014 |
pCpGfree-basic | Disease-related blood-based differential methylation in cystic fibrosis and i... | 2021 | Epigenetics | Schamschula E. et al. | DOI: 10.1080/15592294.2021.1959976 |
ChemiComp GT115 | Disease-related blood-based differential methylation in cystic fibrosis and i... | 2021 | Epigenetics | Schamschula E. et al. | DOI: 10.1080/15592294.2021.1959976 |
pCpGfree-promoter | Disease-related blood-based differential methylation in cystic fibrosis and i... | 2021 | Epigenetics | Schamschula E. et al. | DOI: 10.1080/15592294.2021.1959976 |
IFN-α/β Reporter HEK 293 Cells | Induction of robust type I interferon levels by oncolytic reovirus requires b... | 2021 | Hum Gene Ther. | Oosenbrug T. et al. | DOI: 10.1089/hum.2021.140 |
THP1-Dual™ Cells | Induction of robust type I interferon levels by oncolytic reovirus requires b... | 2021 | Hum Gene Ther. | Oosenbrug T. et al. | DOI: 10.1089/hum.2021.140 |
OVA protein | Synergistic enhancement of immunological responses triggered by hyperthermia ... | 2021 | Bioact Mater. | Yu J. et al. | DOI: 10.1016/j.bioactmat.2021.05.030 |
QUANTI-Luc™: Luciferase Detection Reagent | Soluble trivalent engagers redirect cytolytic T cell activity toward tumor en... | 2021 | Cell Rep Med. | Fierle J.K. et al. | DOI: 10.1016/j.xcrm.2021.100362 |
Jurkat Reporter Cells (NFAT) | Soluble trivalent engagers redirect cytolytic T cell activity toward tumor en... | 2021 | Cell Rep Med. | Fierle J.K. et al. | DOI: 10.1016/j.xcrm.2021.100362 |
ODN 2216 - TLR9 ligand | Compromised mitochondrial quality control triggers lipin1-related rhabdomyoly... | 2021 | Cell Rep Med | Hamel Y. et al. | DOI: 10.1016/j.xcrm.2021.100370 |